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Introduction
Background
HIV incidence reduction has plateaued in the recent years with some population sub-groups still 
being affected disproportionately.1 One of these key populations is adolescents and young adults 
(AYA) with approximately 2.9 million living with HIV in sub-Saharan Africa between the ages of 
15 years and 24 years.2 Research shows that, because of a number of developmental, psychological, 
social and structural transitions that converge in this period of the lifespan, AYA are at increased 
risk of HIV acquisition.3 Moreover, a growing body of neurobiological research and imaging 
studies suggest that adolescents may be prone to engage in risk behaviours, including sexual risk 
taking and substance abuse, because of developmental changes.4 Risk factors for HIV acquisition 
seen in South African youth are the early age of sexual debut, a high number of sexual partners 
and inconsistent use of condoms.5,6
Objectives
At the end of 2015, the South African Medicines Control Council approved a fixed-dose 
combination of tenofovir disoproxil fumarate and emtricitabine for pre-exposure prophylaxis 
(PrEP) of HIV, a new prevention tool in the fight against HIV.7 Previous research showed the 
Background: Approximately 3 million adolescents and young adults (AYA), between the ages 
of 15 years and 24 years, are living with HIV in sub-Saharan Africa. The use of pre-exposure 
prophylaxis (PrEP) may be a promising HIV prevention tool to bridge the high-risk years of 
AYA between sexual debut and adulthood.
Objectives: Concerns have been raised that the use of PrEP could lead to an increase in sexual 
risk behaviour and sexually transmitted infections in general and less condom use in particular 
among adolescents.
Methods: This study assesses condom use among South African adolescents enrolled on a 
demonstration PrEP study, called Pluspills, being conducted in Cape Town and Soweto. 
A questionnaire on sexual risk behaviour was administered at baseline and after 4, 8 and 
12 weeks. Three different questions on condom use were asked at each visit. Unless all answers 
indicated condom use at all times, a participant was scored ‘at risk’. McNemar’s tests and a 
Cochran’s Q test were used to investigate changes in condom use over time.
Results: We interviewed 148 adolescents (66% female) at baseline. Eighty-nine participants 
completed all visits. In this group, an increase in condom use was observed over the period of 
12 weeks. Most participants who reported behavioural changes mentioned an increase in 
condom use.
Conclusion: There was no sign of sexual risk compensation in the 12 weeks of the study. 
Observed increase in condom use can be explained by an increased awareness of personal HIV 
risk or by social desirability or recall biases. In future research, additional data including other 
biomarkers of unprotected sex and longer follow-up time would be useful to help understand 
the relationship between PrEP use, sexual risk perception and consequent behaviours, 
especially in adolescents.
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benefits of PrEP if it is prioritised to high-risk populations, 
is adhered to and does not lead to an increase in risk 
behaviour.8,9,10 Therefore, the use of PrEP may be beneficial in 
preventing HIV infection during the high-risk years of youth, 
as PrEP could offer a time-limited strategy to bridge the 
developmental period in at-risk adolescents from sexual 
debut to adulthood. However, there is a concern that its use 
may result in risk compensation,11 that is, PrEP use might 
inhibit the uptake of safer behaviours by reducing people’s 
perception of their risk of infection.12
Trends
In the past, the potential introduction of other HIV 
prevention technologies, such as vaccines, barrier methods,13 
antiretroviral treatment for prevention, male circumcision14 
and vaginal microbicides,15,16 raised the same public health 
concern. Yet, previous research has not found evidence for 
sexual risk compensation in adults using PrEP17,18,19,20,21,22 or 
post-exposure prophylaxis (PEP).23
Contribution to the field
To date, there has been no research into sexual risk 
compensation among adolescents following the introduction 
of PrEP. With the ongoing roll-out of PrEP programmes and 
an upcoming United Nations Children’s Fund (UNICEF) 
funded project for PrEP implementation for adolescents in 
South Africa, this research question has become urgent. In 
particular there is potential concern that condom use may 
decrease in the short-term as a result of being substituted by 
another prevention intervention, also known as ‘condom 
migration’.15 In this article, we aim to explore short-term 
changes in condom use among HIV-uninfected adolescents 
using PrEP in South Africa.
Research design
Setting
This analysis was part of the Pluspills study24,25 which 
evaluates the use and effectiveness of PrEP among HIV-
uninfected adolescents in South Africa. The Pluspills study is 
an open-label, single-arm cohort study to evaluate patterns 
of PrEP use and patterns of condom use among adolescents 
aged 15 years to 19 years.
Design
The aim was to evaluate the change in condom use (condom 
migration) among participants starting PrEP for a period 
of 12 weeks. All participants received PrEP (FTC/TDF) as 
part of a combination prevention package. This package 
consisted of an individualised adherence plan for PrEP, risk 
reduction counselling, free condoms and condom counselling, 
screening and treatment for sexually transmitted infections 
(STIs) and counselling and referral for other HIV prevention 
interventions (e.g. PEP, voluntary male circumcision). 
Sampling in the study was stratified by gender, because 
women are more vulnerable to HIV acquisition in this setting. 
Community engagement via the adolescent community 
advisory board (CAB) and a consent education discussion 
group prior to screening was done at both sites. The 
discussion groups enabled the study team to explain the 
prevention package, including PrEP, to participants and 
enabled participants to engage with the study team. After 
these meetings, participants were invited to enrol in the 
Pluspills study. The following inclusion criteria had to be 
met: participants must be aged between 15 years and 19 
years old, willing to provide assent or consent, have a 
guardian willing to provide consent, able to provide adequate 
locator information, HIV-uninfected, sexually active, have 
negative pregnancy test, effective method of contraception, 
no intention to relocate, no activities that require long 
absences from the area and willing to undergo all study-
required procedures. At enrolment, participants were asked 
to initiate PrEP as part of a comprehensive prevention 
package for at least three months. Thereafter individuals 
were allowed to opt out of PrEP use should they wish to, 
whilst remaining in the study. The choice to opt out was 
posed at each three-monthly visit. Participants were 
counselled at every visit as part of the combination prevention 
package. Counsellors and clinicians offered participants 
condoms at each visit. Condoms were also available in the 
bathrooms of each clinic.
Procedure
A behavioural questionnaire was administered at baseline 
and at each subsequent visit. The questionnaire aimed to 
collect information on sexual behaviour, risk taking and 
changes over time.
Measurements and coding
The three questions on condom use (consistency of condom 
use, condom use during last sexual act and frequency of 
condom use) were coded as ‘at risk’ (=1) and ‘not at risk’ (=0). 
Only an explicit confirmation of condom use on all three 
questions was scored as ‘not at risk’. Inconsistent condom 
use was defined as any uncertainty in the self-report on 
condom use. If a participant scored 1 on any of the three 
questions she/he was considered ‘at risk’. Participants were 
also asked if and how they changed their sexual behaviour 
between the different time points. Self-reported change was 
used to assess participants’ perception of sexual risk. 
Participants were screened for STIs (Herpes Simplex Virus-2, 
Chlamydia trachomatis and Neisseria gonorrhoeae) at baseline 
and week 12.
Statistical analyses
Baseline condom use data were compared with data points 
after 4, 8 and 12 weeks and these were also compared with 
each other. McNemar’s tests and a Cochran’s Q test were 
used to look for change in condom use over time. In particular, 
the McNemar’s test was used to see if change in condom 
use (=condom migration) was random or because of the 
intervention. Data were analysed using STATA 13.0.
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Ethical consideration
This study was approved by the Division of AIDS (DAIDS), 
Independent Ethics Committees, and South Africa’s 
Medicines Control Council prior to implementation. This 
study was conducted according to the protocol as well as the 
International Conference on Harmonisation of Technical 
Requirements for Registration of Pharmaceuticals for Human 
Use (ICH) and South African Good Clinical Practices.
Results
Demographic information
Eighty-nine participants completed all subsequent visits (see 
Tables 1 and 2): 41 participants at the Desmond Tutu HIV 
Foundation Youth Centre in Masiphumelele, Cape Town and 
48 participants at the Perinatal HIV Research Unit in Soweto, 
Johannesburg. Of the participants who completed all visits, 
58 (65%) were females, as per design. All participants were of 
black ethnicity and lived in the townships of Masiphumelele 
or Soweto. At baseline 75% of the participants attended 
school and 11% attended a tertiary education institute. 
Eighty percent of the sample lived with, at least one of their 
parents; the other 20% lived with their grandparents, other 
family or a guardian. Two-thirds of the sample reported 
inconsistent condom use at baseline. Female participants 
reported more inconsistent condom usage than male 
participants at baseline. The STI numbers were high, with 
37% of the participants having an STI at baseline. STIs were 
more prevalent in female participants than in male 
participants, respectively 47% versus 16%.
Follow-up sexually transmitted infections
In the follow-up, data regarding STI screening were only 
available for 81 out of the 89 participants. Of the participants, 
30% had an STI (Table 3), and 19% had an STI at both time 
TABLE 1: Baseline characteristics.
Characteristic Female (n = 58) Male (n = 31) All (n = 89)
n % n % n %
Location
 Cape Town 26 44.8 15 48.4 41 46.1
 Soweto 32 55.2 16 51.6 48 53.9
School attendance 
 Yes 43 74.1 24 77.4 67 75.3
Highest grade completed
 Senior phase (grade 7–9) 17 29.3 13 41.9 30 33.7
 FET band (grade 10–12) 41 70.1 18 58.1 59 66.3
Attending tertiary education institute
 Yes 6 10.3 4 12.9 10 11.2
Household
 Mother and/or father 47 81.0 24 77.4 71 79.8
 Grandmother and/or -father 4 6.9 2 6.5 6 6.7
 Other 7 12.1 5 16.1 12 13.5
Inconsistent condom use 44 75.9 17 54.8 61 68.5
Condom use (last sexual act) 39 67.2 24 77.42 63 70.8
Sexually transmitted infections 27 46.6 5 16.1 32 36.0
FET, further education and training.
TABLE 2: Age and average grade of participants.
Characteristic Female (n = 58) Male (n = 31) All (n = 89)
Median IQR Mean SD Median IQR Mean SD Median IQR Mean SD
Age in years 18.0 16.0–19.0 17.41 1.43 18.0 17.0–18.0 17.58 0.99 18.0 17.0–18.0 17.47 1.29
Average grade 10.0 9.0–12.0 10.29 1.31 10.0 9.0–11.0 10.00 1.32 10.0 9.0–11.0 10.19 1.31
n, number; IQR, interquartile range; SD, standard deviation.
TABLE 3: Sexually transmitted infections.
Characteristics STI rates (week 12)
All (n = 81)Yes No
n % n % n %
Gender
 Male 5 6.2 19 23.5 24 29.6
 Female 19 23.5 35 43.2 57 70.4
Sexual transmitted infection (baseline)
 Yes 15 18.5 15 18.5 30 37.0
 No 9 11.1 42 51.9 51 63.0
Consistent condom use (week 4–12) 
 At risk 19 23.5 46 56.8 65 80.2
 Not at risk 5 6.2 11 13.6 16 19.8
n, number; STI, sexually transmitted infection.
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points. At week 12, five participants had an STI despite 
reporting consistent condom use on all intermediate time 
points.
Condom migration
McNemar’s tests showed an increase in condom use 
between baseline and week 8, baseline and week 12, and 
week 4 and week 12 (see Table 4). The Cochran’s Q test 
with all data points also showed an increase in condom use 
over time (see Table 4). Approximately 28% of the 
participants reported a change in sexual behaviour 
between the different visits. Of them, 87% (81% – 92%) 
reported using condoms more often than before. During 
the follow-up period, fewer participants were classified ‘at 
risk’ because of more consistent condom use reported over 
time (see Figure 1).
Discussion
Outline of the results
We did not see a reduction in condom use over this relatively 
short period of time in a South African adolescent population 
commencing PrEP. Reported condom use was similar to 
previous research of condom use patterns in adolescents in 
South Africa.5,26 What is more is that in this relatively small 
sample we observed an increase in self-reported condom use. 
We can hypothesise multiple explanations for this finding. 
Firstly, this reporting is valid and may be because of the 
benefits of repeated risk reduction counselling, provision 
of condoms, enhanced awareness of potential risk because 
of provision of PrEP and more partner support because of 
enrolment in a study. Secondly, this finding can be false 
reporting as a result of social desirability or recall biases in 
self-reported condom use. Whilst ongoing surveillance of 
sexual risk compensation is warranted in PrEP implementation, 
these data are at least encouraging.
Limitations
A total of 148 participants completed the baseline visit, but 
only 89 participants completed all three subsequent visits. 
Whilst a comparison of demographic baseline data and 
baseline reported sexual behaviour between participants 
who attended their visits and the ones who missed a visit 
showed no difference, the analysis was carried out only in 
those who attended all three survey time points. This limited 
the number of participants in the study. Secondly, a limitation 
of the study was that condom use was based on self-report 
which can be influenced by social desirability or recall biases. 
Using other biomarkers of unprotected sex may be a more 
reliable measure of current risk behaviour.27 STI rates can be 
a surrogate to validate self-reported condom use. Despite 
self-reported consistency in condom use, five participants 
had an STI after 12 weeks, perhaps raising some questions 
around the validity of consistent condom use.
Conclusion and recommendations
To our knowledge, this is the first study of condom migration 
among adolescents on PrEP. Three months is a relatively 
short period, although this is the time that all adolescents 
were expected to consistently be using daily PrEP in Pluspills. 
Whilst more research is needed to understand the relationship 
between PrEP use, sexual risk behaviour, perception of risk 
and consequent behaviours, especially among adolescents, 
these preliminary and limited results are encouraging. Whilst 
PrEP may well be a very important intervention prevention 
addition to the tool box for adolescents, it is also understood 
that it should always be administered as part of a broader 
package that also includes risk reduction counselling, 
condom provision, contraception and STI screening as part of 
adolescent-friendly services.
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